logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Over the first six months of 2015, the market has not performed very well. Since the 1st of the year, the DJIA has essentially remained the same (down 0.4% to be exact). The S&P 500 has also practically remained the same. The NASDAQ has had modest gains, but nothing exceptional.…
Read more...
Over the first six months of 2015, the market has not performed very well. Since the 1st of the year, the DJIA has essentially remained the same (down 0.4% to be exact). The S&P 500 has also remained practically unchanged. The NASDAQ has had modest gains, but nothing exceptional. But while…
Read more...
The life sciences industry is evolving rapidly. Many say it's at the beginning of an explosive growth stage that will see the development and commercialization of novel therapeutics and diagnostics still being imagined in scientific laboratories today. This explosion of innovation also means an explosion of investment opportunity. In this…
Read more...
Natera (NTRA) is a rapidly growing diagnostics company with proprietary molecular and bioinformatics technology that NTRA is deploying to change the management of genetic disease worldwide. It is based in San Carlos, CA. Three other companies are scheduled to IPO for the week of June 29. The full IPO calendar…
Read more...
Mr. Albert Scardino, Chairman of the Board of Immunovaccine Inc. (IMV.TO) / (IMMVF) (market cap ~ C$ 80 million) was kind enough to take time from his busy schedule to allow me, Peter Epstein, CFA, MBA to interview him. I met Mr. Scardino in New York last week and was intrigued by the story. I have no prior or existing…
Read more...
It’s been a big week for the Supreme Court. They have made a number of decisions in the last week that will shape the way the country operates moving forward. Here’s a brief recap of all the decisions the High Court handed down last week. Glossip v. Gross June 29,…
Read more...
Teladoc (TDOC) is the nation's first and largest telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone. The company is based in Purchase, NY. Three other companies are scheduled to IPO for the week of June 29. The full IPO calendar is available at…
Read more...
In the lead up to commercialization, drugs need to be tested for safety and efficacy, and chemicals need to be tested for acute toxicity to humans and animals. That process is expensive and time-consuming; even an extremely simple toxicity study in rats can take a month and cost $50,000. Typically,…
Read more...
Any sports fan that has ever turned on ESPN would recognize the name Dr. James Andrews. He’s internationally known for his accomplishments, not on the playing field, but rather his skills in the operating room. Dr. Andrews is one of the most recognized names in modern day sports with a…
Read more...
Biotech investors are abuzz over immune checkpoint inhibitors and T-cell therapies, but which ones do you pick? JonesTrading Institutional Services Senior Equity Analyst George Zavoico is moving rapidly to initiate coverage on some key names in this space, and is casting a wide net in hopes of catching winners. In…
Read more...
So far this year, the biotech sector is once again outperforming the broad market. The equally-weighted SPDR S&P Biotech ETF ($XBI) is up more than the S&P 500 as of this writing. If the year closes in the same vein, it will be the fifth consecutive year of outperformance. After…
Read more...
The list of problems with investing in micro-cap biotech stocks begins with extreme volatility and lack of liquidity and ends with the inability to get validation from sophisticated investors who are unable to own such small companies. Nevertheless, sift through the pile and investors can find gems. Joseph Pantginis of…
Read more...
Page 1 of 53

 

 Today's Must Reads

Microsegmentation: The Future of Cybersecurity?


How this Playboy Playmate Became a Better Stock Trader Than You

Long Term Rates Are On The Up…What’s Next?

The Modern Web: So Many Ways to Invest in Wireless Mobile Stocks

It's Time for the Rest of the Country to Legalize Weed

 

Do you expect a 10% correction by the end of 2015? in Equities.com Polls on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN